California Public Employees Retirement System’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-142,800
Closed -$648K 3108
2021
Q1
$648K Sell
142,800
-13,165
-8% -$70.9K ﹤0.01% 2796
2020
Q4
$895K Sell
155,965
-2,900
-2% -$22K ﹤0.01% 2558
2020
Q3
$1.15M Buy
158,865
+5,500
+4% +$29.4K ﹤0.01% 2181
2020
Q2
$535K Buy
153,365
+56,965
+59% +$164K ﹤0.01% 2643
2020
Q1
$143K Hold
96,400
﹤0.01% 2998
2019
Q4
$189K Buy
96,400
+75,800
+368% +$285K ﹤0.01% 3126
2019
Q3
$105K Buy
20,600
+982
+5% +$5.95K ﹤0.01% 3088
2019
Q2
$140K Buy
+19,618
New +$222K ﹤0.01% 3025
2019
Q1
Sell
-46,028
Closed -$362K 3242
2018
Q4
$362K Sell
46,028
-8,392
-15% -$79.9K ﹤0.01% 2693
2018
Q3
$603K Buy
+54,420
New +$676K ﹤0.01% 2589
2018
Q2
Sell
-37,096
Closed -$482K 3343
2018
Q1
$482K Sell
37,096
-15,836
-30% -$197K ﹤0.01% 2633
2017
Q4
$487K Buy
+52,932
New +$452K ﹤0.01% 2673

Other funds holding CBAY

California Public Employees Retirement System's CBAY Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Cymabay Therapeutics (CBAY) in Q2 2021, closing a stake of 142,800 shares — an estimated $648K sold.

California Public Employees Retirement System first reported a position in CBAY in Q4 2017 and held it in 12 quarters. The position peaked at $1.15M in Q3 2020. 113 funds tracked by Wall St. Rank hold CBAY as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Cymabay Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 142,800 Cymabay Therapeutics shares in Q2 2021, an estimated $648K.
  • California Public Employees Retirement System first reported a position in Cymabay Therapeutics in Q4 2017 and held it in 12 quarters.
  • California Public Employees Retirement System's Cymabay Therapeutics position peaked at $1.15M in Q3 2020.
  • 113 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.